Last 1,584 INR
Change Today -0.65 / -0.04%
Volume 1.2M
WPL On Other Exchanges
Symbol
Exchange
Natl India
As of 6:06 AM 02/28/15 All times are local (Market data is delayed by at least 15 minutes).

wockhardt ltd (WPL) Snapshot

Open
1,593
Previous Close
1,584
Day High
1,609
Day Low
1,554
52 Week High
02/26/15 - 1,618
52 Week Low
03/21/14 - 432.00
Market Cap
174.3B
Average Volume 10 Days
2.1M
EPS TTM
76.64
Shares Outstanding
110.1M
EX-Date
11/13/14
P/E TM
20.7x
Dividend
20.00
Dividend Yield
1.26%
Current Stock Chart for WOCKHARDT LTD (WPL)

Related News

No related news articles were found.

wockhardt ltd (WPL) Related Businessweek News

No Related Businessweek News Found

wockhardt ltd (WPL) Details

Wockhardt Limited, a pharmaceutical and biotechnology company, together with its subsidiaries, manufactures and markets pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs), and vaccines. It provides pharmaceutical products in various dosage forms, such as sterile injectables and lyophilised products in the therapeutic areas of anti-infectives, cardiology, dermatology, diabetology, neurology, pain management, respiratory, and other areas. The company offers generic products that comprise injectables, including cephalosporins and non-cephalosporins; and value-added generics. Its biopharmaceutical products include Glargine that is recombinant long-acting insulin; Wosulin, which is r-DNA insulin; Wepox, a recombinant erythropoietin is used in the treatment of anaemia caused by cancer and chronic renal failure; and Biovac-B, a hepatitis B vaccine. The company also provides contract manufacturing and packaging services for sterile injectables, lyophilisation, solid dose, liquids/ointments/creams, sachets and powders, and specialized products; API manufacturing services; and contract research services. Its research activities comprise pharmaceutical formulations, biopharmaceutical bulk and formulations, novel drug delivery systems, new drug discovery programs, and process engineering for APIs. The company develops various molecules primarily in the area of anti-infectives, which include WCK 771 that is in Phase II human clinical trials for the treatment of staphylococcal infections; and WCK 2349, WCK 4873, and WCK 4086 lead molecules, which are under pre-clinical trials. Wockhardt Limited offers its products in India, the United States, Europe, and other countries. The company was incorporated in 1999 and is headquartered in Mumbai, India. Wockhardt Limited is a subsidiary of Khorakiwala Holdings and Investments Private Limited.

8,600 Employees
Last Reported Date: 08/19/14
Founded in 1999

wockhardt ltd (WPL) Top Compensated Officers

Managing Director, Executive Director, Member...
Total Annual Compensation: 13.3M
Founder, Executive Chairman, Group Chief Exec...
Total Annual Compensation: 4.8M
Executive Director, Member of Share Allotment...
Total Annual Compensation: 13.3M
Compensation as of Fiscal Year 2014.

wockhardt ltd (WPL) Key Developments

Wockhardt Ltd. Announces Executive Changes

The Board of Wockhardt Ltd announced the resignation of Mr. Nimesh S. Shah as Company Secretary and Compliance Officer of the Company with effect from close of working hours of February 9, 2015. Further, Ms. Amruta Avasare, Assistant Company Secretary will act as Compliance Officer of the Company till the appointment of new Company Secretary.

Wockhardt Ltd., Board Meeting, Feb 25, 2015

Wockhardt Ltd., Board Meeting, Feb 25, 2015. Agenda: To allot 6,750 equity shares.

Wockhardt Limited Announces Executive Changes

Wockhardt Limited announced that the Board noted the resignation of Mr. Nimesh S. Shah as Company Secretary and Compliance Officer of the company with effect from close of working hours of February 9, 2015. Further, Ms. Amruta Avasare, Assistant Company Secretary will act as Compliance Officer of the company till the appointment of new Company Secretary.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WPL:IN 1,583.70 INR 0.00

WPL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cadila Healthcare Ltd 1,547 INR +13.65
Cipla Ltd/India 682.05 INR +12.20
Endo International PLC $85.60 USD +0.36
Ipca Laboratories Ltd 656.85 INR -6.80
Torrent Pharmaceuticals Ltd 1,074 INR +31.25
View Industry Companies
 

Industry Analysis

WPL

Industry Average

Valuation WPL Industry Range
Price/Earnings 40.4x
Price/Sales 4.1x
Price/Book 5.3x
Price/Cash Flow 30.2x
TEV/Sales 3.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WOCKHARDT LTD, please visit www.wockhardt.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.